Links
[1] http://ghr.nlm.nih.gov/gene/GLA
[2] https://disorders.eyes.arizona.edu/disorders/fucosidosis
[3] http://omim.org/entry/230000
[4] https://disorders.eyes.arizona.edu/disorders/williams-syndrome
[5] http://omim.org/entry/194050
[6] https://disorders.eyes.arizona.edu/disorders/retinal-arteriolar-tortuosity
[7] http://omim.org/entry/611773
[8] http://omim.org/entry/180000
[9] https://disorders.eyes.arizona.edu/references/favourable-effect-early-versus-late-start-enzyme-replacement-therapy-plasma
[10] https://disorders.eyes.arizona.edu/references/cilioretinal-artery-occlusion-and-anterior-ischemic-optic-neuropathy-initial-presentation
[11] https://disorders.eyes.arizona.edu/references/enzyme-replacement-therapy-anderson-fabry-disease-cochrane-database-syst-rev
[12] https://disorders.eyes.arizona.edu/references/chronic-kidney-disease-and-uncertain-diagnosis-fabry-disease-approach-correct-diagnosis
[13] https://disorders.eyes.arizona.edu/references/fabry-disease-multidisciplinary-evaluation-after-10-years-treatment-agalsidase-beta
[14] https://disorders.eyes.arizona.edu/references/continuous-cardiac-troponin-i-release-fabry-disease
[15] https://disorders.eyes.arizona.edu/references/agalsidase-alfa-review-its-use-management-fabry-disease
[16] https://disorders.eyes.arizona.edu/references/life-expectancy-and-cause-death-males-and-females-fabry-disease-findings-fabry-registry
[17] https://disorders.eyes.arizona.edu/references/ophthalmological-manifestations-farbry-disease-survey-patients-royal-melbourne-fabry
[18] https://disorders.eyes.arizona.edu/references/fabry-disease-overall-effects-agalsidase-alfa-treatment
[19] https://disorders.eyes.arizona.edu/references/ocular-manifestations-fabry-disease-survey-32-hemizygous-male-patients